Directori de persones
Felipe Vilardell Villellas

Felipe Vilardell Villellas

Grau: Doctor/a


fvilardell.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-6631-2011

Publicacions

  • Matas-Nadal C; Soria X; Gonzalez-Farré M; Baradad M; Tuset N; Rius Riu F; González M; Gatius S; Vilardell F; López-Ortega R; María Martí R

    Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships.

    European Journal of Medical Genetics 65 104609-104609. .

    [doi:10.1016/j.ejmg.2022.104609]

  • Alturo-Pons A; Alamon-Reig F; Sanmartin Novell V; Vilardell F; Martí RM

    Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.

    ACTAS DERMO-SIFILIOGRAFICAS -. .

    [doi:10.1016/j.ad.2022.01.048]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Vieites, B; Lopez-Garcia, MA; Martin-Salvago, MD; Ramirez-Tortosa, CL; Rezola, R; de Salas, MS; Vilaro, LL; Villellas, FV; Burgues, O; Fernandez-Rodriguez, B; Galan, LA; Peg, V

    Patient follow-up of NEOVATTL study

    ANNALS OF ONCOLOGY 32 49-49. .

    [doi:10.1016/j.annonc.2021.03.079]

  • Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI

    Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

    BREAST 56 52-53. .

  • Morales Murillo, Serafin; Gasol Cudos, Ariadna; Veas Rodriguez, Joel; Canosa Morales, Carles; Melé Olivé, Jordi; Vilardell Villellas, Felip; Sanchez Guzman, Douglas Rene; Iglesias Martínez, Edelmiro; Salud Salvia, Antonieta

    Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

    BREAST 56 35-41. .

    [doi:10.1016/j.breast.2021.01.001]

  • Murillo, SM; Cudos, AG; Rodriguez, JV; Morales, CC; Olive, JM; Villellas, FV; Guzman, DRS; Martinez, EI; Salvia, AS

    Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

    Future Science Oa 7 -. .

    [doi:10.2144/fsoa-2020-0146]

  • Murillo, SM; Cudos, AG; Subirats, OP; Olive, JM; Morales, CC; Villellas, FV; Guzman, DRS; Rodriguez, JV; Galindo, AR

    Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer

    CANCER RESEARCH 81 -. .

  • Cudos, AG; Murillo, SM; Subirats, OP; Villellas, FV; Guzman, DRS; Morales, CC; Olive, JM; Sanchez, AV; Ortega, JFC

    Relapse pattern after neoadjuvant treatment in early breast cancer

    ANNALS OF ONCOLOGY 32 437-437. .

    [doi:10.1016/j.annonc.2021.08.461]

  • Bonet, M; Rodrigo, A; Vazquez, S; Carrizo, V; Vilardell, F; Mira, M

    Adjuvant therapy for true ampullary cancer: a systematic review.

    CLINICAL & TRANSLATIONAL ONCOLOGY 22 1407-1413. .

    [doi:10.1007/s12094-019-02278-6]

  • Garcia-de-la-Fuente, MR; Santacana, M; Verdaguer, J; Vilardell, F; Gari, E; Casanova, JM

    Characterisation of the inflammatory response triggered by topical ingenol mebutate 0.05% gel in basal cell carcinoma.

    Australasian Journal of Dermatology 61 200-207. .

    [doi:10.1111/ajd.13229]

  • Matas-Nadal, Clara; Fernández-Armenteros, Josep Manel; Vilardell, Felip; Casanova, Josep Manel; Aguayo Ortiz, Rafael S.

    Carcinoma ecrino: dos casos de una neoplasia inusual y revisión de la literatura

    Piel 35 159-165. .

    [doi:10.1016/j.piel.2019.08.009]

Projectes

  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica